Acumen Pharmaceuticals Inc (ABOS) — Tangible Net Worth Ratio
Acumen Pharmaceuticals Inc (ABOS) has a Tangible Net Worth Ratio of 100.0% as of March 2026. This metric is calculated by deducting intangible assets ($24.00K) from net assets ($87.48 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Acumen Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Acumen Pharmaceuticals Inc Tangible Net Worth Ratio (2021–2025)
This chart shows how Acumen Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 5 annual periods from 2021 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting net assets of $87.48 Million with intangible assets of $24.00K USD. For live market cap and overall valuation, see Acumen Pharmaceuticals Inc (ABOS) total market value.
Annual Tangible Net Worth Ratio for Acumen Pharmaceuticals Inc (2021–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Acumen Pharmaceuticals Inc from 2021 to 2025, covering 5 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See financial agility of Acumen Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $70.43 Million | $29.00K | $122.83 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $181.82 Million | $75.00K | $238.99 Million | ▲ +0.0 pp |
| 2023 | 99.9% | $266.97 Million | $169.00K | $310.12 Million | ▼ -0.1 pp |
| 2022 | 100.0% | $188.78 Million | $0.00 | $196.59 Million | ▲ +0.0 pp |
| 2021 | 100.0% | $225.18 Million | $0.00 | $230.33 Million | — |